Page last updated: 2024-12-07

bis-benzimidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bis-benzimidazole: in vitro inhibitor of arenavirus synthesis; studied in treatment of lymphocytic choriomeningitis virus infections; also used as its di-HCl salt, A37536; RN given refers to parent cpd with unspecified isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130471
SCHEMBL ID7740448
MeSH IDM0054644

Synonyms (12)

Synonym
1,2-bis(6-methoxy-1h-benzimidazol-2-yl)ethane-1,2-diol
bis-benzimidazole
16656-27-2
1,2-ethanediol, 1,2-bis(5-methoxy-1h-benzimidazol-2-yl)-
(s,s)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethanediol
a-36683
abbot 36683
a 37536
SCHEMBL7740448
1,2-bis(5-methoxy-2-benzimidazol-2-yl)-1,2-ethanediol
DTXSID70276316
MZMNCFAGSTVAOQ-UHFFFAOYSA-N

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In addition, DMA is non-toxic to mammalian cells at antibiotic dosage level."( 3,4-dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I.
Bansal, S; Cheng, B; Singh, M; Sinha, D; Tandon, V; Tse-Dinh, YC, 2012
)
0.7
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.78)18.7374
1990's3 (8.33)18.2507
2000's12 (33.33)29.6817
2010's15 (41.67)24.3611
2020's5 (13.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.25 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (97.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]